Toxicology is the vital part of pharmacology which deals with the undesirable effect
of phytocompounds on living organisms before they are use as drug or chemical in
clinical use. This study is aimed at evaluating the acute and sub-acute toxicity effects
of Lonchocarpus laxiflorus leaf methanol extracts (LLMLE). Standard OECD guidelines
were used to conduct acute and subchronic toxicity evaluations. The results of acute
oral administration of the leaf extracts indicated no mortality up to 14 days after
treatment. There was also no sign of toxicity, and the LD50 was assumed to be greater
than 3000mg/kg. In sub-chronic toxicity, there was no significant (P>0.05) alteration in
animal bodyweight throughout the experimental period suggesting that the extract
did not interfere with feeding or regulate appetite. There was also no significant
(P>0.05) alteration in all liver biomarkers of all Lonchocarpus laxiflorus leaf methanol
extracts treated groups compared to control. Lonchocarpus laxiflorus leaf methanol
extracts (LLMLE) did not cause any significant (P>0.05) alteration in kidney function
parameters. Similarly, there were no significant (P>0.05) alteration in haematological
parameters of all Lonchocarpus laxiflorus leaf methanol extracts treated groups
compared to control. Hence, Lonchocarpus laxiflorus leaf methanol extract is not
hepatotoxic, nephrotoxic and do not have a haematological effect, thus this research
validates the safety of this plant at acute and subchronic administrations
Keywords: Acute, sub-acute, toxicity, Lonchocarpus laxiflorus